Sum composition results

AbbreviationFormulaMassMain ClassSub Class
GlcNAcβ1-4Manβ1-4Glcβ-Cer 34:1;O2C54H100N2O181064.697119Neutral glycosphingolipids [SP05]GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508]
GlcNAcβ1-4Manβ1-4Glcβ-Cer 36:1;O2C56H104N2O181092.728419Neutral glycosphingolipids [SP05]GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508]
GlcNAcβ1-4Manβ1-4Glcβ-Cer 38:1;O2C58H108N2O181120.759719Neutral glycosphingolipids [SP05]GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508]
GlcNAcβ1-4Manβ1-4Glcβ-Cer 40:1;O2C60H112N2O181148.791019Neutral glycosphingolipids [SP05]GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508]
GlcNAcβ1-4Manβ1-4Glcβ-Cer 42:2;O2C62H114N2O181174.806669Neutral glycosphingolipids [SP05]GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508]
GlcNAcβ1-4Manβ1-4Glcβ-Cer 42:1;O2C62H116N2O181176.822320Neutral glycosphingolipids [SP05]GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508]
GlcNAcβ1-4Manβ1-4Glcβ-Cer 44:2;O2C64H118N2O181202.837970Neutral glycosphingolipids [SP05]GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508]
GlcNAcβ1-4Manβ1-4Glcβ-Cer 44:1;O2C64H120N2O181204.853620Neutral glycosphingolipids [SP05]GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508]